Raising awareness about rare conditions and the unique challenges that individuals face is crucial for developing effective therapies and treatments. Patient advocacy in life sciences is becoming increasingly important as a result of this.
Life sciences leaders are taking note, recognizing the need to incorporate health consumers’ perspectives when it comes to product and therapy development. However, codifying processes to incorporate the patient perspective is a challenge many life sciences organizations face.
We were lucky to speak with a few Salesforce employees who were willing to share their stories to help illustrate areas of patient advocacy and their importance. Here are four steps life sciences organizations can take to improve patient experiences and develop more patient-centric approaches to drug and therapy discovery, development, and marketing.
Build a more connected pharma operation
Learn how pharmaceutical companies can drive patient and afghanistan phone number list customer engagement with an integrated technology platform.
Download the free guide
1. Increase patient engagement during research and development
A growing body of evidence shows that people who are well-informed and are motivated to actively engage in their healthcare have better health outcomes. However, it’s equally important for researchers to include patients early in the research and development phase to understand the effects across a broad range of participants with a wide spectrum of internal or external factors that influence outcomes.
There has been a shift in the industry with more organizations working directly with people who have personal experience with the conditions. Pharma companies can work with these organizations to increase patient involvement and improve the experience.